Is the treatment of left ventricular systolic dysfunction different according to the etiology?

Cardiac failure is the terminal stage of evolution, the finality of many valvular, vascular, myocardial, general, congenital or acquired conditions. The therapeutic decisions should be based on the search for a curable cause of a predisposing factor and the evaluation of the severity of the cardiac...

Full description

Saved in:
Bibliographic Details
Published inArchives des maladies du coeur et des vaisseaux Vol. 91; no. 11; p. 1359
Main Author Bounhoure, J P
Format Journal Article
LanguageFrench
Published France 01.11.1998
Subjects
Cardiovascular Surgical Procedures
Decision Making
Drug Therapy
Heart Failure - etiology
Heart Failure - therapy
Humans
Patient Care Planning
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - therapy
Ventricular Remodeling
Online AccessGet more information

Cover

More Information
Summary:Cardiac failure is the terminal stage of evolution, the finality of many valvular, vascular, myocardial, general, congenital or acquired conditions. The therapeutic decisions should be based on the search for a curable cause of a predisposing factor and the evaluation of the severity of the cardiac failure. At advanced stages of ventricular dysfunction when the myocardial lesions are constituted, when cardiac and vascular remodelling has occurred, the aetiological treatment, which is the constant objective, is unfortunately too late. The treatment is the same, whatever the aetiology, in order to improve functional problems. At early stages, and, if possible, preventively, surgery, revascularisation techniques, the correction of an arrhythmia, the suppression of a cardiotoxic factor, are essential. The different therapeutic classes used could have different efficacies depending on the aetiology, but, finally, this point is negligible: the medications are based on the results of large scale, controlled, therapeutic trials.
ISSN:0003-9683